This review highlights the genetic basis of familial chylomicronaemia syndrome, emphasizing the critical roles of LPL and apoC-II in triglyceride metabolism.
No takes yet. Share an insight, caveat, or question.
Supports genetic testing for LPL/APOC2 mutations in severe hypertriglyceridemia; leaves open optimal therapies pending prospective data.
Fojo et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: